Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Doctors should make sure immunizations are up to date before cochlear implant surgery in children, new guidelines from the American Academy of Pediatrics…
NEW YORK (Reuters Health) – Patients with febrile neutropenia on high doses of cefepime may be at risk for neurological toxicity, according to a study published online July…
NEW YORK (Reuters Health) – HIV therapy needs to start earlier and guidelines are being changed to reflect that, officials said this weekend at the International AIDS Conference…
NEW YORK (Reuters Health) – Outcomes are better for patients with total coronary artery occlusions when percutaneous coronary intervention is performed with sirolimus-eluting stents rather than with bare…
NEW YORK (Reuters Health) – Eptifibatide and tirofiban are effective alternatives to abciximab given during primary percutaneous intervention for ST-elevation MI, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
NEW YORK (Reuters Health) – A course of intravenous antibiotic therapy lasting no more than 3 days for hospitalized infants with urinary tract infections is just as successful…
NEW YORK (Reuters Health) – Children and adolescents with juvenile idiopathic arthritis who have a clinical response to treatment with the biologic agent abatacept experience a significant improvement…
NEW YORK (Reuters Health) – Urinary tract infections occur quite often after patients are given detrusor injections of botulinum toxin A (BoNT-A) to reduce bladder overactivity, so prophylactic…
NEW YORK (Reuters Health) – First-line therapy with zidovudine and interferon-alpha improves overall survival in patients with adult T-cell leukemia/lymphoma (ATL), according to the results of a retrospective…
